Becton, Dickinson ROA 2006-2018 | BDX

Current and historical return on assets (ROA) values for Becton, Dickinson (BDX) over the last 10 years.
Becton, Dickinson Annual ROA - Return on Assets
2017 2.92
2016 3.82
2015 2.63
2014 9.52
2013 7.65
2012 9.77
2011 11.51
2010 11.55
2009 12.55
2008 13.62
2007 11.48
2006 11.94
2005 11.62
Becton, Dickinson Quarterly ROA - Return on Assets
Q3 2018 1.10
Q2 2018 -0.02
Q1 2017 -0.25
Q4 2017 0.87
Q3 2017 -0.36
Q2 2017 1.43
Q1 2016 2.31
Q4 2016 0.08
Q3 2016 1.50
Q2 2016 1.29
Q1 2015 0.88
Q4 2015 0.69
Q3 2015 0.23
Q2 2015 0.76
Q1 2014 1.27
Q4 2014 2.42
Q3 2014 2.64
Q2 2014 2.34
Q1 2013 2.25
Q4 2013 0.75
Q3 2013 2.52
Q2 2013 2.37
Q1 2012 2.32
Q4 2012 2.42
Q3 2012 2.83
Q2 2012 2.46
Q1 2011 2.18
Q4 2011 2.44
Q3 2011 3.03
Q2 2011 3.01
Q1 2010 3.12
Q4 2010 2.40
Q3 2010 3.26
Q2 2010 3.19
Q1 2009 3.34
Q4 2009 2.80
Q3 2009 3.83
Q2 2009 3.42
Q1 2008 4.04
Q4 2008 2.97
Q3 2008 3.64
Q2 2008 3.53
Q1 2007 3.58
Q4 2007 3.20
Q3 2007 3.38
Q2 2007 3.39
Q1 2006 1.92
Q4 2006 3.18
Q3 2006 3.40
Q2 2006 2.67
Q1 2005 3.59
Q4 2005 2.31
Q3 2005 3.16
Q2 2005 3.11
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $66.998B $12.093B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
Align Technology (ALGN) United States $29.611B 78.94
McKesson (MCK) United States $25.307B 9.69
Laboratory Of America Holdings (LH) United States $18.402B 16.92
AmerisourceBergen (ABC) United States $18.267B 13.27
Cardinal Health (CAH) United States $15.587B 10.45
Cooper (COO) United States $12.520B 23.31
Henry Schein (HSIC) United States $11.981B 20.43
DENTSPLY SIRONA (XRAY) United States $8.671B 15.18
West Pharmaceutical Services (WST) United States $8.622B 44.58
Merit Medical Systems (MMSI) United States $3.052B 40.11
CONMED (CNMD) United States $2.189B 37.09
Patterson (PDCO) United States $2.173B 13.61
STAAR Surgical (STAA) United States $1.868B 250.00
Atrion (ATRI) United States $1.217B 36.08
Invacare (IVC) United States $0.540B 0.00
Antares Pharma (ATRS) United States $0.512B 0.00
Endologix (ELGX) United States $0.206B 0.00
Lifevantage (LFVN) United States $0.142B 29.32
Aceto (ACET) United States $0.099B 4.03
Biolase (BIOL) United States $0.031B 0.00
Pro-Dex (PDEX) United States $0.029B 12.60
Milestone Scientific (MLSS) United States $0.028B 0.00
Retractable Technologies (RVP) United States $0.024B 0.00